Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Modified Constraint-Induced Movement Therapy vs. Mirror Therapy for hemiplegic stroke

Official title: Comparison of the Effects of Modified Constraint-Induced Movement Therapy and Mirror Therapy Applied to the Upper Extremity on Motor Function, Participation, and Independence in Activities of Daily Living in Hemiplegic Stroke Patients: A Randomized Controlled Trial

Run by Ondokuz Mayıs University · NCT07668349 · Data updated 2026-11-12

This study tests whether modified constraint-induced movement therapy or mirror therapy better helps people with one-sided arm weakness after stroke.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment16 (estimated)
SponsorOndokuz Mayıs University
Academic / other
Locations1 site (Kastamonu, Merkez)
StatusRecruiting
StartedFebruary 19, 2026
Main results expectedSeptember 20, 2026
Study endsDecember 2026
Registry record updatedJune 25, 2026
Trial IDNCT07668349 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a first ischemic or hemorrhagic stroke, 3–24 months post-stroke, with mild to moderate arm impairment and adequate cognitive function.

Probably not a fit

Patients with severe comorbidities, very severe motor impairment, or insufficient cognitive ability may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with stroke and hemiplegia are randomly assigned to receive either Modified Constraint-Induced Movement Therapy or Mirror Therapy. The trial compares effects on upper-limb motor function, daily activities, and overall independence, using standard care as a baseline. It follows a prospective, randomized, single-blind design with ethical approval and informed consent. Outcomes focus on paretic limb recovery and quality of life.

Why it matters

Potential benefit: If successful, the preferred therapy could improve arm function and independence for stroke survivors.

How similar studies have gone: Previous work suggests both methods can aid recovery, but head-to-head evidence is limited; this trial aims to provide direct comparison.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \* Diagnosis: Confirmed first ischemic or hemorrhagic stroke with clinical and neurological evaluation.

  * Time Since Stroke: 3 to 24 months post-stroke onset.
  * Hemiplegia: Significant motor deficit in the affected upper extremity.
  * Motor Function Level: Presence of mild to moderate motor impairment in the affected upper extremity (FMA-UE score appropriate for the application of modified CIMT and mirror therapy).
  * Cognitive Status: Adequate cognitive capacity to understand and follow the study protocols (Mini-Mental State Examination score of 20 or above).
  * Visual Perception: Adequate visual perception to perform mirror therapy.
  * Comorbidities: Absence of severe coexisting medical conditions that prevent participation (e.g., uncontrolled cardiovascular diseases, severe psychiatric disorders).
  * Prior Treatments: No prior intensive participation in the interventions investigated in this study (modified CIMT or mirror therapy).
  * Consent: Voluntary agreement to participate and signed informed consent form.

Exclusion Criteria:

* \* Uncontrolled diabetes or other metabolic disorders.

  * Progressive non-stroke neurological diseases (e.g., Parkinson's disease, multiple sclerosis).
  * Terminal illness or short life expectancy.
  * Severe cognitive impairment preventing comprehension or execution of the study protocols (e.g., advanced dementia).
  * Severe visual impairment that prevents mirror therapy application (e.g., uncorrected visual acuity loss, neglect).
  * Severe visuospatial perception disorders making it difficult to perceive or interpret the mirror image.
  * Absence or minimal level of active movement in the affected upper extremity (limiting the applicability of modified CIMT).
  * Significant motor deficit in the unaffected upper extremity.
  * Severe and uncontrolled spasticity in the upper extremity.

Where it's running

  • Akay Special Education and Rehabilitation Center
    Kastamonu, Merkez, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.